The following is a summary of “Low-dose interleukin-2 in birch pollen allergy: a phase-2 randomized double-blind placebo-controlled trial,” published in the November 2024 issue of Allergy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback